Updates from a single-center phase 2 study of PD-1 inhibitor combined with hypomethylating agent plus CAG regimen in patients with relapsed/refractory acute myeloid leukemia by Hui-Sheng Zhou, Hui-Sheng Zhou, Yong-Feng Su, Jun Wang, Ya-Lei Hu, Ya-Lei Hu, An Wang, Lei Xu, Yi-Zhi Wang, Xuan Zheng, Yu-Qing Li, Yu-Qing Li, Kai-Li Min, Kai-Li Min, Chun-Ji Gao, Dai-Hong Liu, Dai-Hong Liu, Xiao-Ning Gao, Xiao-Ning Gao

Get full text